{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:39:06Z","timestamp":1772156346678,"version":"3.50.1"},"posted":{"date-parts":[[2023,5,4]]},"group-title":"Microbiology","reference-count":35,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Mechanisms by which\n                  <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                  (Mtb) evades pathogen recognition receptor activation during infection may offer insights for the development of improved tuberculosis (TB) vaccines. Whilst Mtb elicits NOD-2 activation through host recognition of its peptidoglycan-derived muramyl dipeptide (MDP), it masks the endogenous NOD-1 ligand through amidation of glutamate at the second position in peptidoglycan sidechains. As the current BCG vaccine is derived from pathogenic mycobacteria, a similar situation prevails. To alleviate this masking ability and to potentially improve efficacy of the BCG vaccine, we used CRISPRi to inhibit expression of the essential enzyme pair, MurT-GatD, implicated in amidation of peptidoglycan sidechains. We demonstrate that depletion of these enzymes results in reduced growth, cell wall defects, increased susceptibility to antibiotics and altered spatial localization of new peptidoglycan. In cell culture experiments, training of monocytes with this recombinant BCG yielded improved control of Mtb growth. In the murine model of TB infection, we demonstrate that depletion of MurT-GatD in BCG, resulting in unmasking of the D-glutamate diaminopimelate (iE-DAP) NOD-1 ligand, yields superior prevention of TB disease compared to the standard BCG vaccine. This work demonstrates the feasibility of gene regulation platforms such as CRISPRi to alter antigen presentation in BCG in a bespoke manner that tunes immunity towards more effective protection against TB disease.\n                <\/jats:p>","DOI":"10.1101\/2023.05.03.539199","type":"posted-content","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T08:05:21Z","timestamp":1683187521000},"source":"Crossref","is-referenced-by-count":0,"title":["A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice"],"prefix":"10.64898","author":[{"given":"Moagi T.","family":"Shaku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Um","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl L.","family":"Ocius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis J.","family":"Apostolos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos M.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-3480","authenticated-orcid":false,"given":"Bavesh D.","family":"Kana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023050608050984000_2023.05.03.539199v1.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1216166"},{"key":"2023050608050984000_2023.05.03.539199v1.2","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/CVI.00349-16","article-title":"In vitro experimental model of trained innate immunity in human primary monocytes","volume":"23","year":"2016","journal-title":"Clinical Vaccine Immunology"},{"key":"2023050608050984000_2023.05.03.539199v1.3","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5RI0315-096R"},{"key":"2023050608050984000_2023.05.03.539199v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-9792(02)00089-6"},{"key":"2023050608050984000_2023.05.03.539199v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.010"},{"key":"2023050608050984000_2023.05.03.539199v1.6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60083"},{"key":"2023050608050984000_2023.05.03.539199v1.7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.vaccine.2021.01.068","article-title":"Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?","volume":"40","year":"2022","journal-title":"Vaccine"},{"key":"2023050608050984000_2023.05.03.539199v1.8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100900"},{"key":"2023050608050984000_2023.05.03.539199v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.022"},{"key":"2023050608050984000_2023.05.03.539199v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2003.08.003"},{"key":"2023050608050984000_2023.05.03.539199v1.11","first-page":"e00679","article-title":"Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG \u0394ureC:: hly improves protection against tuberculosis","volume":"7","year":"2016","journal-title":"MBio"},{"key":"2023050608050984000_2023.05.03.539199v1.12","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00466-14"},{"key":"2023050608050984000_2023.05.03.539199v1.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044582"},{"key":"2023050608050984000_2023.05.03.539199v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.12.031"},{"key":"2023050608050984000_2023.05.03.539199v1.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109"},{"key":"2023050608050984000_2023.05.03.539199v1.16","first-page":"1","article-title":"Pattern recognition receptors in health and diseases","volume":"6","year":"2021","journal-title":"Signal transduction targeted therapy"},{"key":"2023050608050984000_2023.05.03.539199v1.17","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20167449"},{"key":"2023050608050984000_2023.05.03.539199v1.18","doi-asserted-by":"crossref","first-page":"100088","DOI":"10.1016\/j.tcsw.2022.100088","article-title":"Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC","volume":"8","year":"2022","journal-title":"The Cell Surface"},{"key":"2023050608050984000_2023.05.03.539199v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz016"},{"key":"2023050608050984000_2023.05.03.539199v1.20","doi-asserted-by":"crossref","first-page":"dlab028","DOI":"10.1093\/jacamr\/dlab028","article-title":"Characterization of the MurT\/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target","volume":"3","year":"2021","journal-title":"JAC-antimicrobial resistance"},{"key":"2023050608050984000_2023.05.03.539199v1.21","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","year":"2022","journal-title":"The Lancet Global Health"},{"key":"2023050608050984000_2023.05.03.539199v1.22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jpha.2020.09.003","article-title":"Fluorescent antibiotics for real-time tracking of pathogenic bacteria","volume":"10","year":"2020","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"2023050608050984000_2023.05.03.539199v1.23","first-page":"15","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","year":"2021","journal-title":"The Journal of clinical investigation"},{"key":"2023050608050984000_2023.05.03.539199v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0148-2"},{"key":"2023050608050984000_2023.05.03.539199v1.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002509"},{"key":"2023050608050984000_2023.05.03.539199v1.26","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1002\/chem.201706082","article-title":"Critical Impact of Peptidoglycan Precursor Amidation on the Activity of L, D-Transpeptidases from Enterococcus faecium and Mycobacterium tuberculosis","volume":"24","year":"2018","journal-title":"Chemistry\u2013A European Journal"},{"key":"2023050608050984000_2023.05.03.539199v1.27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10753-020-01211-2","article-title":"Oat-derived \u03b2-glucans induced trained immunity through metabolic reprogramming","volume":"43","year":"2020","journal-title":"Inflammation"},{"key":"2023050608050984000_2023.05.03.539199v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(11)80416-0"},{"key":"2023050608050984000_2023.05.03.539199v1.29","first-page":"2185","article-title":"L,D-Transpeptidase Specific Probe Reveals Spatial Activity of Peptidoglycan Cross-Linking","volume":"14","year":"2019","journal-title":"ACS chemical biology"},{"key":"2023050608050984000_2023.05.03.539199v1.30","first-page":"1","article-title":"Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform","volume":"2","year":"2017","journal-title":"Nature microbiology"},{"key":"2023050608050984000_2023.05.03.539199v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.058"},{"key":"2023050608050984000_2023.05.03.539199v1.32","doi-asserted-by":"crossref","first-page":"100246","DOI":"10.1016\/j.xpro.2020.100246","article-title":"Preparation and culture of bone marrow-derived macrophages from mice for functional analysis","volume":"2","year":"2021","journal-title":"STAR protocols"},{"key":"2023050608050984000_2023.05.03.539199v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68507-3"},{"key":"2023050608050984000_2023.05.03.539199v1.34","first-page":"1023","volume":"29","year":"2018","journal-title":"Epigenetics and trained immunity"},{"key":"2023050608050984000_2023.05.03.539199v1.35","unstructured":"WHO (2022). World health organization (WHO) global tuberculosis report 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240061729."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.05.03.539199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:37:14Z","timestamp":1768451834000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.05.03.539199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1101\/2023.05.03.539199","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.7554\/eLife.89157","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.89157","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2023,5,4]]},"subtype":"preprint"}}